Literature DB >> 15021926

[Drug therapy of acute manias. A retrospective data analysis of inpatients from 1997 to 1999].

M Letmaier1, D Schreinzer, N Thierry, R Wolf, S Kasper.   

Abstract

The aim of the present retrospective chart analysis was to compare published treatment algorithms with the treatment patterns of 90 consecutive inpatients suffering from acute mania or hypomania at the Department of General Psychiatry, University of Vienna, from 1997 to 1999. Treatment strategies during the first 14 days and on discharge as well as sociodemographic and illness related data were evaluated. The results of our study reflect that international guidelines were not included in daily practice from 1997 to 1999 with regard to the usage pattern of atypical antipsychotics versus typical neuroleptics. Also, recommendations have not been taken into account about monotherapy with a mood stabilizer as first-line treatment for acute mania (polypharmacia was the predominant treatment scheme) and the advice to taper off benzodiazepines (at discharge).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021926     DOI: 10.1007/s00115-003-1554-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  30 in total

1.  The treatment of manic psychoses by the administration of lithium salts.

Authors:  M SCHOU; N JUEL-NIELSEN; E STROMGREN; H VOLDBY
Journal:  J Neurol Neurosurg Psychiatry       Date:  1954-11       Impact factor: 10.154

2.  A double-blind comparison of valproate and lithium in the treatment of acute mania.

Authors:  T W Freeman; J L Clothier; P Pazzaglia; M D Lesem; A C Swann
Journal:  Am J Psychiatry       Date:  1992-01       Impact factor: 18.112

3.  Efficacy of lithium as acute treatment of manic-depressive illness.

Authors:  P E Stokes; C A Shamoian; P M Stoll; M J Patton
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

4.  Importance of psychiatric diagnosis in prediction of clinical drug effects.

Authors:  D F Klein
Journal:  Arch Gen Psychiatry       Date:  1967-01

5.  Depression and poststroke mortality.

Authors:  J A Cooney
Journal:  Am J Psychiatry       Date:  1994-01       Impact factor: 18.112

6.  Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.

Authors:  M Berk; L Ichim; S Brook
Journal:  Int Clin Psychopharmacol       Date:  1999-11       Impact factor: 1.659

7.  Double-blind comparison of the effects of clonazepam and lorazepam in acute mania.

Authors:  J Bradwejn; C Shriqui; D Koszycki; G Meterissian
Journal:  J Clin Psychopharmacol       Date:  1990-12       Impact factor: 3.153

8.  Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.

Authors:  M Tohen; T M Sanger; S L McElroy; G D Tollefson; K N Chengappa; D G Daniel; F Petty; F Centorrino; R Wang; S L Grundy; M G Greaney; T G Jacobs; S R David; V Toma
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

Review 9.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.

Authors:  Heinz Grunze; Siegfried Kasper; Guy Goodwin; Charles Bowden; David Baldwin; Rasmus W Licht; Eduard Vieta; Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2003-01       Impact factor: 4.132

10.  A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania.

Authors:  P E Garfinkel; H C Stancer; E Persad
Journal:  J Affect Disord       Date:  1980-12       Impact factor: 4.839

View more
  3 in total

Review 1.  [Problems of evidence-based medicine in psychopharmacotherapy: problems of evidence grading and of the evidence basis for complex clinical decision making].

Authors:  H-J Möller; W Maier
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

Review 2.  [Treatment options for bipolar mania].

Authors:  T Attarbaschi; S Kasper
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

3.  A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.

Authors:  Rodrigo Machado-Vieira; Jair C Soares; Diogo R Lara; David A Luckenbaugh; João V Busnello; Getulio Marca; Angelo Cunha; Diogo O Souza; Carlos A Zarate; Flavio Kapczinski
Journal:  J Clin Psychiatry       Date:  2008-08       Impact factor: 4.384

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.